1. Home
  2. STEM vs CRBU Comparison

STEM vs CRBU Comparison

Compare STEM & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stem Inc.

STEM

Stem Inc.

HOLD

Current Price

$11.85

Market Cap

75.3M

Sector

Technology

ML Signal

HOLD

Logo Caribou Biosciences Inc.

CRBU

Caribou Biosciences Inc.

HOLD

Current Price

$2.35

Market Cap

179.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STEM
CRBU
Founded
2009
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
75.3M
179.7M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
STEM
CRBU
Price
$11.85
$2.35
Analyst Decision
Hold
Strong Buy
Analyst Count
3
4
Target Price
$13.33
$10.75
AVG Volume (30 Days)
102.3K
1.3M
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
3.64
EPS
N/A
N/A
Revenue
$156,266,000.00
N/A
Revenue This Year
$2.77
$1.63
Revenue Next Year
$14.65
$10.93
P/E Ratio
N/A
N/A
Revenue Growth
8.08
N/A
52 Week Low
$0.35
$0.73
52 Week High
$32.23
$3.53

Technical Indicators

Market Signals
Indicator
STEM
CRBU
Relative Strength Index (RSI) 62.68 67.00
Support Level $10.93 $1.70
Resistance Level $12.05 $2.66
Average True Range (ATR) 0.72 0.11
MACD 0.34 0.03
Stochastic Oscillator 89.37 88.18

Price Performance

Historical Comparison
STEM
CRBU

About STEM Stem Inc.

Stem Inc is a provider of energy storage systems. The company bundles third-party hardware with its proprietary Athena software to provide customers a turnkey solution. Stem sells its solutions to commercial and industrial customers as well as independent power producers and renewable developers. Its solutions help customers maximize renewable energy generation and help build a cleaner and more resilient grid. The Company operates as one operating segment that is focused exclusively on technology services that transform the way energy is distributed and consumed.

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.

Share on Social Networks: